Atopaxar
98%
- Product Code: 110368
CAS:
751475-53-3
| Molecular Weight: | 527.63 g./mol | Molecular Formula: | C₂₉H₃₈FN₃O₅ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, sealed, dry |
Product Description:
Atopaxar is primarily researched for its potential application in the prevention and treatment of cardiovascular diseases. It functions as a protease-activated receptor-1 (PAR-1) antagonist, which plays a crucial role in inhibiting platelet activation. By blocking this receptor, it helps reduce the risk of thrombotic events, such as heart attacks and strokes, particularly in patients with acute coronary syndrome or those undergoing percutaneous coronary interventions. Its unique mechanism offers a promising alternative to traditional antiplatelet therapies, especially for patients who may not respond well to existing treatments. Clinical studies continue to explore its efficacy and safety profile in various patient populations.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Off-White Solid |
| Purity (%) | 97.5-100% |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1mg | 10-20 days | ฿4,110.00 |
+
-
|
| 5mg | 10-20 days | ฿14,110.00 |
+
-
|
| 10mg | 10-20 days | ฿25,740.00 |
+
-
|
| 25mg | 10-20 days | ฿56,640.00 |
+
-
|
| 50mg | 10-20 days | ฿89,600.00 |
+
-
|
Atopaxar
Atopaxar is primarily researched for its potential application in the prevention and treatment of cardiovascular diseases. It functions as a protease-activated receptor-1 (PAR-1) antagonist, which plays a crucial role in inhibiting platelet activation. By blocking this receptor, it helps reduce the risk of thrombotic events, such as heart attacks and strokes, particularly in patients with acute coronary syndrome or those undergoing percutaneous coronary interventions. Its unique mechanism offers a promising alternative to traditional antiplatelet therapies, especially for patients who may not respond well to existing treatments. Clinical studies continue to explore its efficacy and safety profile in various patient populations.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :